CD147 and AGR2 expression promote cellular proliferation and metastasis of head and neck squamous cell carcinoma.

[1]  Xiaojie Zhu,et al.  Association of increased ligand cyclophilin A and receptor CD147 with hypoxia, angiogenesis, metastasis and prognosis of tongue squamous cell carcinoma , 2012, Histopathology.

[2]  Chang-yun Yu,et al.  Downregulation of EphA2 expression suppresses the growth and metastasis in squamous-cell carcinoma of the head and neck in vitro and in vivo , 2012, Journal of Cancer Research and Clinical Oncology.

[3]  E. Rosenthal,et al.  Fibroblast Growth Factor Receptor Mediates Fibroblast-Dependent Growth in EMMPRIN-Depleted Head and Neck Cancer Tumor Cells , 2011, Molecular Cancer Research.

[4]  Chang-yun Yu,et al.  Clinical significance of EphA2 expression in squamous-cell carcinoma of the head and neck , 2011, Journal of Cancer Research and Clinical Oncology.

[5]  Pu Xia,et al.  Up-regulated EMMPRIN/CD147 protein expression might play a role in colorectal carcinogenesis and its subsequent progression without an alteration of its glycosylation and mRNA level , 2011, Journal of Cancer Research and Clinical Oncology.

[6]  Kyusam Choi,et al.  AGR2, a mucinous ovarian cancer marker, promotes cell proliferation and migration , 2011, Experimental & Molecular Medicine.

[7]  Yingying Wu,et al.  CXCR4 Promotes Oral Squamous Cell Carcinoma Migration and Invasion through Inducing Expression of MMP-9 and MMP-13 via the ERK Signaling Pathway , 2011, Molecular Cancer Research.

[8]  S. Horvath,et al.  Differential expression of anterior gradient gene AGR2 in prostate cancer , 2010, BMC Cancer.

[9]  C. Pilarsky,et al.  Prognostic significance of AGR2 in pancreatic ductal adenocarcinoma. , 2009, Histology and histopathology.

[10]  C. Pan,et al.  EMMPRIN expression in tongue squamous cell carcinoma. , 2009, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[11]  E. Rosenthal,et al.  Anti-EMMPRIN Monoclonal Antibody as a Novel Agent for Therapy of Head and Neck Cancer , 2009, Clinical Cancer Research.

[12]  Yasuhiro Nakagami,et al.  The protein disulfide isomerase AGR2 is essential for production of intestinal mucus , 2009, Proceedings of the National Academy of Sciences.

[13]  E. Rosenthal,et al.  Modulation of tumor cell growth in vivo by extracellular matrix metalloprotease inducer. , 2008, Archives of otolaryngology--head & neck surgery.

[14]  Zhe-Sheng Chen,et al.  Proteome analysis of multidrug resistance of human oral squamous carcinoma cells using CD147 silencing. , 2008, Journal of proteome research.

[15]  E. Rosenthal,et al.  Fluorescent labeled anti‐EGFR antibody for identification of regional and distant metastasis in a preclinical xenograft model , 2008, Head & neck.

[16]  Zheng Wang,et al.  The adenocarcinoma-associated antigen, AGR2, promotes tumor growth, cell migration, and cellular transformation. , 2008, Cancer research.

[17]  E. Moran,et al.  Physiological stress induces the metastasis marker AGR2 in breast cancer cells , 2007, Molecular and Cellular Biochemistry.

[18]  I. Petersen,et al.  Expression of AGR2 in non small cell lung cancer. , 2007, Histology and histopathology.

[19]  E. Rosenthal,et al.  Sensitivity and specificity of fluorescent immunoguided neoplasm detection in head and neck cancer xenografts. , 2007, Archives of otolaryngology--head & neck surgery.

[20]  E. Rosenthal,et al.  Use of fluorescent labeled anti–epidermal growth factor receptor antibody to image head and neck squamous cell carcinoma xenografts , 2007, Molecular Cancer Therapeutics.

[21]  C. Tzao,et al.  Expression of EMMPRIN and matriptase in esophageal squamous cell carcinoma: correlation with clinicopathological parameters. , 2006, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[22]  K. Tsuneyama,et al.  Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis , 2006, British Journal of Cancer.

[23]  G. Sauter,et al.  High incidence of EMMPRIN expression in human tumors , 2006, International journal of cancer.

[24]  E. Carlson,et al.  Characterization of 3 oral squamous cell carcinoma cell lines with different invasion and/or metastatic potentials. , 2006, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[25]  Jean Wu,et al.  Increased EMMPRIN (CD 147) expression during oral carcinogenesis. , 2006, Experimental and molecular pathology.

[26]  G. Kristiansen,et al.  Prognostic Relevance of AGR2 Expression in Breast Cancer , 2006, Clinical Cancer Research.

[27]  Yi Tang,et al.  Immunolocalization of EMMPRIN (Cd147) in the Human Eye and Detection of Soluble Form of EMMPRIN in Ocular Fluids , 2006, Current eye research.

[28]  J. Cheville,et al.  AGR2, an androgen‐inducible secretory protein overexpressed in prostate cancer , 2005, Genes, chromosomes & cancer.

[29]  A. Anderson,et al.  A hybrid mathematical model of solid tumour invasion: the importance of cell adhesion , 2005 .

[30]  Dong Liu,et al.  Human homologue of cement gland protein, a novel metastasis inducer associated with breast carcinomas. , 2005, Cancer research.

[31]  Yi Tang,et al.  Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases. , 2005, Cancer research.

[32]  E. Rosenthal,et al.  Extracellular Matrix Metalloprotease Inducer–Expressing Head and Neck Squamous Cell Carcinoma Cells Promote Fibroblast-Mediated Type I Collagen Degradation In vitro , 2005, Molecular Cancer Research.

[33]  J. Xing,et al.  Function of HAb18G/CD147 in Invasion of Host Cells by Severe Acute Respiratory Syndrome Coronavirus , 2005, The Journal of infectious diseases.

[34]  Li Yan,et al.  Roles of the multifunctional glycoprotein, emmprin (basigin; CD147), in tumour progression , 2005, Thrombosis and Haemostasis.

[35]  Rongsong Li,et al.  Emmprin Promotes Anchorage-Independent Growth in Human Mammary Carcinoma Cells by Stimulating Hyaluronan Production , 2004, Cancer Research.

[36]  E. Rosenthal,et al.  Expression of Extracellular Matrix Metalloprotease Inducer in Laryngeal Squamous Cell Carcinoma , 2003, The Laryngoscope.

[37]  W. Hait,et al.  Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells. , 2003, Molecular cancer research : MCR.

[38]  Hiroshi Shinkai,et al.  Expression of matrix metalloproteinase-1, -2 and -3 in squamous cell carcinoma and actinic keratosis , 1999, British Journal of Cancer.

[39]  R. Weigel,et al.  hAG-2, the human homologue of the Xenopus laevis cement gland gene XAG-2, is coexpressed with estrogen receptor in breast cancer cell lines. , 1998, Biochemical and biophysical research communications.

[40]  T. Salo,et al.  Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis. , 1998, British Journal of Cancer.

[41]  H. Guo,et al.  The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. , 1995, Cancer research.

[42]  A. Passaniti,et al.  ErbB3 binding protein 1 represses metastasis-promoting gene anterior gradient protein 2 in prostate cancer. , 2010, Cancer research.

[43]  C. Lebbé,et al.  Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasion. , 2007, Cancer research.

[44]  P. Rudland,et al.  Increased expression of anterior gradient-2 is significantly associated with poor survival of prostate cancer patients , 2007, Prostate Cancer and Prostatic Diseases.

[45]  T. Yoshizaki,et al.  Inhibition of cervical lymph node metastasis by marimastat (BB-2516) in an orthotopic oral squamous cell carcinoma implantation model , 2004, Clinical & Experimental Metastasis.

[46]  X. Li,et al.  Expression of emmprin by oral squamous cell carcinoma. , 2000, International journal of cancer.